Sepracor, Inc
Article Abstract:
The price appreciation potential of the shares of Sepracor Inc. for the years 2010-2012 is discussed. The Marlborough, Massachusetts-based specialty pharmaceutical company offers improved versions of currently marketed drugs or Improved Chemical Entities for allergy/asthma, urology/gastroenterology, and psychology/neurology.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Valeant Pharmac
Article Abstract:
The price appreciation potential of the shares of Valeant Pharmaceuticals for the years 2010-2012 is discussed. The Costa Mesa, California-based company offers a variety of drugs and other medical products, including anti-infectives, dermatologicals, vitamins, anticholinesterases, and vision care.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Par Pharm
Article Abstract:
The price appreciation potential of the shares of Par Pharmaceutical Companies Inc. for the years 2010-2012 is discussed. The Spring Valley, New York-based holding company offers generic drugs in the United States through its subsidiary Par Pharmaceutical Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
User Contributions:
Comment about this article or add new information about this topic: